ChromaDex Corporation operates as a nutraceutical company. The company offers research and quality control products and services to dietary supplements, food, beverages, cosmetic, and pharmaceutical industries; Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide(NAD) level used for healthy aging; Pterostilbene (pTeroPure), a polyphenol and antioxidant used in health related fields; and Immulina, a spirulina extract and compound, which is used for improving human immune function, as well as developing Pterostilbene and caffeine co-crystal ingredients, and anthocyanins ingredients. It also provides reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. In addition, the company offers a range of consulting services, including regulatory support, product development, risk management, and litigation support. Further, it assists customers in creating processes for manufacturing natural products using green chemistry, as well as developing phytochemical libraries. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation has a strategic partnership for healthy aging research with the Jiangxi Provincial Government, the People’s Republic of China. ChromaDex Corporation is based in Irvine, California.

“We had another strong quarter,” said ChromaDex CEO Rob Fried. “In addition, we improved the gross margin and expanded our global footprint.” https://investors.chromadex.com/news/news-details/2019/ChromaDex-Corporation-Reports-Third-Quarter-2019-Financial-Results/default.aspx

ChromaDex Chief Scientific Advisor Dr. Charles Brenner, VP of Regulatory Affairs Dr. Andrew Shao, and Chief Scientific Officer Dr. Matthew Roberts at @CRN_Supplements #DayofScience19 in Carlsbad, CA. #HealthyAging

“Aging is not a solved problem...Aging will happen, the question is whether we age well or age rapidly,” says Dr. @CharlesMBrenner during his presentation, “Development of Nicotinamide Riboside to Address Conditions of Metabolic Stress,” at CRN’s #DayofScience19 #HealthyAging

Congratulations to our Scientific Advisory Board member Dr. @RudyTanzi for receiving the @TheBRF 2019 Dr. Frederic A. Gibbs Discovery Award for scientific achievement!

“The findings highlight an emerging area of research in the physiological uniqueness of NR as a NAD precursor and furthers our understanding of the role NR plays in liver health,” Dr. Matthew Roberts, Chief Scientific Officer at ChromaDex.
https://investors.chromadex.com/news/news-details/2019/New-Study-Demonstrates-a-Unique-Role-of-Nicotinamide-Riboside-Over-Other-NAD-Precursors/default.aspx

Load More...

FULL NAME*

What's Your Role?*

WORK EMAIL*

COMPANY NAME*

Company Description*

HOW'D YOU HEAR ABOUT US?

DETAILS ABOUT YOUR GOALS

ChromaDex Corporation

10005 Muirlands Boulevard
Suite G
Irvine, CA 92618

+1 (949) 419-0288

www.chromadex.com

November 2019
S M T W T F S
« Oct    
 12
3456789
10111213141516
17181920212223
24252627282930

©2019 ALIGNMT LLC | Alignment Strategy | Mergers & Acquisitions | Investor Relations

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account